Skip to main content
EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · IEX Real-Time Price · USD
9.71
+0.25 (2.64%)
At close: Jul 26, 2024, 4:00 PM
9.89
+0.18 (1.81%)
After-hours: Jul 26, 2024, 5:32 PM EDT

EyePoint Pharmaceuticals Revenue

EyePoint Pharmaceuticals had revenue of $11.68M in the quarter ending March 31, 2024, with 52.08% growth. This brings the company's revenue in the last twelve months to $50.02M, up 25.70% year-over-year. In the year 2023, EyePoint Pharmaceuticals had annual revenue of $46.02M with 11.14% growth.

Revenue (ttm)
$50.02M
Revenue Growth
+25.70%
P/S Ratio
10.11
Revenue / Employee
$413,380
Employees
121
Market Cap
505.74M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202346.02M4.61M11.14%
Dec 31, 202241.40M4.47M12.09%
Dec 31, 202136.94M2.50M7.27%
Dec 31, 202034.44M14.07M69.10%
Dec 31, 201920.37M15.79M345.53%
Dec 31, 2018 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sharecare 419.82M
Pacific Biosciences of California 200.43M
Treace Medical Concepts 196.03M
biote 187.32M
Valneva SE 166.26M
Theravance Biopharma 61.51M
Nano-X Imaging 10.01M
Absci 5.35M
Revenue Rankings

EYPT News

More News